Circular RNAs in Human Cancer

Circular RNAs (circRNAs) are a class of endogenous single-stranded covalently closed RNAs, primarily produced from pre-mRNAs via non-canonical back-splicing. circRNAs are highly conserved, stable, and expressed in tissue- and development-specific pattern. circRNAs play essential roles in physiologic...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 10; p. 577118
Main Authors Wang, Xiong, Li, Huijun, Lu, Yanjun, Cheng, Liming
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Circular RNAs (circRNAs) are a class of endogenous single-stranded covalently closed RNAs, primarily produced from pre-mRNAs via non-canonical back-splicing. circRNAs are highly conserved, stable, and expressed in tissue- and development-specific pattern. circRNAs play essential roles in physiological process as well as cancer biology. By the advances of deep sequencing and bioinformatics, the number of circRNAs have increased explosively. circRNAs function as miRNA/protein sponge, protein scaffold, protein recruitment, enhancer of protein function, as well as templates for translation involved in the regulation of transcription/splicing, translation, protein degradation, and pri-miRNA processing in human cancers and contributed to the pathogenesis of cancer. Numerous circRNAs may function in diverse manners. In this review, we survey the current understanding of circRNA functions in human cancer including miRNA sponge, circRNA-protein interaction, and circRNA-encoded protein, and summarize available databases for circRNA annotation and functional prediction.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Sebastian Giusti, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Marilia Seelaender, University of São Paulo, Brazil
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
These authors have contributed equally to this work
Edited by: Aamir Ahmad, University of Alabama at Birmingham, United States
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2020.577118